Condition: Hypertrophic Cardiomyopathy · Sponsor: Magdi Yacoub Heart Foundation
Egyptian HCM program aims at defining incidence, severity, phenotype, genotype and determinants of the disease in Egypt, and providing state-of-the-art treatment strategies including medical, surgical and interventional procedures which are patient- and disease-specific.
This description comes directly from the study's public registry record.
Magdi H Yacoub, FRS OM · m.yacoub@imperial.ac.uk
Shehab M Anwer, MBBCh., MRes · +41788816333 · shehabanwer@gmail.com
Always discuss trial participation with your own doctor first.
| Aswan Heart Centre - Magdi Yacoub Heart Foundation | Aswān, Egypt | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05884892